[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100340390":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":34,"centralContacts":38,"locations":43,"responsibleParty":63,"collaborators":28,"id":66,"slug":28,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":28,"eligibilityCriteria":71,"healthyVolunteers":67,"sex":72,"minAge":73,"maxAge":28,"enrollmentInfo":74,"targetDuration":28,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":28,"overallStatus":45,"whyStopped":28,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Ohio State University Comprehensive Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Diagnostic (resection, OCT)","EXPERIMENTAL","Participants undergo resection. Resected tissues are analyzed via ultra-high resolution OCT.",[13,14,15],"Procedure: Optical Coherence Tomography","Procedure: Therapeutic Conventional Surgery","Diagnostic Test: Laboratory Evaluation",[17,24,29],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"PROCEDURE","Optical Coherence Tomography","Undergo OCT",[9],[23],"OCT",{"type":18,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"Therapeutic Conventional Surgery","Undergo resection will be undertaken",[9],null,{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":28},"DIAGNOSTIC_TEST","Laboratory Evaluation","Labs will be obtained to test for cancer cell derived exosomes",[9],[35],{"name":36,"affiliation":5,"role":37},"Mary Dillhoff, MD","PRINCIPAL_INVESTIGATOR",[39],{"name":5,"role":40,"phone":41,"phoneExt":28,"email":42},"CONTACT","800-293-5066","OSUCCCClinicaltrials@osumc.edu",[44],{"facility":5,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"RECRUITING","Columbus","Ohio","43210","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-82.99879,39.96118,{"lat":55,"lon":54},[58,62],{"name":59,"role":40,"phone":60,"phoneExt":28,"email":61},"Mary E. Dillhoff, MD","614-293-7171","Mary.Dillhoff@osumc.edu",{"name":59,"role":37,"phone":28,"phoneExt":28,"email":28},{"type":37,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":28,"oldOrganization":28},"Mary Dillhoff","Principal Investigator","100340390",false,"NCT03711890","Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer","Imaging and Detection of Micrometer Sized Early Stage Pancreatic Cancer by Using Endoscopic Ultra-High Resolution Optical Coherence Tomography (OCT) Using Resected Pancreatic Specimen, a Pilot Study","Inclusion Criteria:\n\n* Immediate surgery cohort: Adult patients with pancreatic cancer or IPMN\n* Immediate surgery cohort: Informed consent will be obtained\n* Adult patients undergoing pancreatic resection for a presumed IPMN\n\nExclusion Criteria:\n\n* Pregnant","ALL","18 Years",{"count":75,"type":76},75,"ESTIMATED","INTERVENTIONAL",[79],"NA","This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.",[82,83],"Pancreatic Carcinoma","Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type","2026-06-11",{"date":86,"type":87},"2026-06-15","ACTUAL",{"date":89,"type":87},"2019-03-26",{"date":91,"type":76},"2026-09-15",{"name":5,"class":6},1]